{"DataElement":{"publicId":"3671771","version":"1","preferredName":"Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Pathologic Group Stage","preferredDefinition":"Stage group determined from pathologic information on the tumor (T), regional node (N) and metastases (M) and by grouping cases with similar prognosis for breast carcinoma.","longName":"3134018v1.0:3419357v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3134018","version":"1","preferredName":"Breast Tumor Pathologic Stage Grouping","preferredDefinition":"information related to the assessment of a neoplasm of the breast based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)_Caused by or altered by or manifesting disease or pathology._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.","longName":"2206465v1.0:2230144v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2230144","version":"1","preferredName":"Pathologic Stage Grouping","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:Stage Grouping; an assessment based on the combined evaluation of the patient's T stage, M stage, and N stage. (caDSR)","longName":"C25610:C38027","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F752037A-4CCE-36A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-05-18","modifiedBy":"ONEDATA","dateModified":"2005-05-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8F0AE4D0-7A75-674F-E040-BB89AD437513","latestVersionIndicator":"Yes","beginDate":"2010-08-30","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-08-30","modifiedBy":"TAYLORT","dateModified":"2019-05-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3419357","version":"1","preferredName":"Breast Cancer American Joint Committee on Cancer (AJCC) Edition 7 Group Stage","preferredDefinition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3419357v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Stage unknown","valueDescription":"Stage Unknown","ValueMeaning":{"publicId":"3357508","version":"1","preferredName":"Stage Unknown","longName":"3357508","preferredDefinition":"A finding indicating that the extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage Unknown","conceptCode":"C92207","definition":"The extent of organ/tissue involvement by a malignant neoplasm is not reported or not assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B6D76279-6263-2CA8-E040-BB89AD434A54","latestVersionIndicator":"Yes","beginDate":"2012-01-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-01-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-1872-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IV","valueDescription":"Stage IV Breast Cancer","ValueMeaning":{"publicId":"3419358","version":"1","preferredName":"Stage IV Breast Cancer","longName":"3419358","preferredDefinition":"Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IV Breast Cancer AJCC v6 and v7","conceptCode":"C3995","definition":"Stage IV includes: Any T, Any N, M1.  M1: Distant metastasis. (AJCC 6th and 7th Eds.)","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-187E-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-1897-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IIIC","valueDescription":"Stage IIIC Breast Cancer","ValueMeaning":{"publicId":"3419360","version":"1","preferredName":"Stage IIIC Breast Cancer","longName":"3419360","preferredDefinition":"Stage IIIC includes: Any T, N3, M0.  N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIC Breast Cancer AJCC v7","conceptCode":"C88377","definition":"Stage IIIC includes: Any T, N3, M0.  N3: Metastases in ipsilateral infraclavicular (level III) axillary lymph nodes(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-18A4-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-18BD-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IIIB","valueDescription":"Stage IIIB Breast Cancer","ValueMeaning":{"publicId":"3419362","version":"1","preferredName":"Stage IIIB Breast Cancer","longName":"3419362","preferredDefinition":"Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0).  T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules).  N0: No regional lymph node metastasis.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIB Breast Cancer AJCC v7","conceptCode":"C7782","definition":"Stage IIIB includes: (T4, N0, M0); (T4, N1, M0); (T4, N2, M0).  T4: Tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or skin nodules).  N0: No regional lymph node metastasis.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-18CA-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-18E3-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IIIA","valueDescription":"Stage IIIA Breast Cancer","ValueMeaning":{"publicId":"3419364","version":"1","preferredName":"Stage IIIA Breast Cancer","longName":"3419364","preferredDefinition":"Stage IIIA includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  T3: Tumor more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIIA Breast Cancer AJCC v7","conceptCode":"C7770","definition":"Stage IIIA includes: (T0, N2, M0); (T1, N2, M0); (T2, N2, M0); (T3, N1, M0); (T3, N2, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  T3: Tumor more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N2: Metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-18F0-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-1909-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IIB","valueDescription":"Stage IIB Breast Cancer","ValueMeaning":{"publicId":"3419366","version":"1","preferredName":"Stage IIB Breast Cancer","longName":"3419366","preferredDefinition":"Stage IIB includes: (T2, N1, M0); (T3, N0, M0).  T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  T3: Tumor more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIB Breast Cancer AJCC v6 and v7","conceptCode":"C5455","definition":"Stage IIB includes: (T2, N1, M0); (T3, N0, M0).  T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  T3: Tumor more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-1916-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-192F-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IIA","valueDescription":"Stage IIA Breast Cancer","ValueMeaning":{"publicId":"3419368","version":"1","preferredName":"Stage IIA Breast Cancer","longName":"3419368","preferredDefinition":"Stage IIA includes: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IIA Breast Cancer AJCC v6 and v7","conceptCode":"C5454","definition":"Stage IIA includes: (T0, N1, M0); (T1, N1, M0); (T2, N0, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension. T2: Tumor more than 20 mm but not more than 50 mm in greatest dimension.  N1: Metastasis to movable ipsilateral level I, II axillary lymph node(s).  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-193C-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-1955-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IB","valueDescription":"Stage IB Breast Cancer","ValueMeaning":{"publicId":"3419370","version":"1","preferredName":"Stage IB Breast Cancer","longName":"3419370","preferredDefinition":"Stage IB includes: (T0, N1mi, M0); (T1, N1mi, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  N1mi: Nodal micrometastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IB Breast Cancer AJCC v7","conceptCode":"C85836","definition":"Stage IB includes: (T0, N1mi, M0); (T1, N1mi, M0).  T0: No evidence of primary tumor.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  N1mi: Nodal micrometastases.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-1962-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-197B-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"IA","valueDescription":"Stage IA Breast Cancer","ValueMeaning":{"publicId":"3419372","version":"1","preferredName":"Stage IA Breast Cancer","longName":"3419372","preferredDefinition":"Stage IA includes: T1, N0, M0.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage IA Breast Cancer AJCC v7","conceptCode":"C85835","definition":"Stage IA includes: T1, N0, M0.  T1: Tumor 20 mm or less in greatest dimension.  T1 includes T1mi. T1mi: Tumor 1 mm or less in greatest dimension.  N0: No regional lymph node metastasis.  M0: No clinical or radiographic evidence of distant metastasis.  M0 includes M0(i+).  (AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-1988-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-19A1-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"},{"value":"0","valueDescription":"Stage 0 Breast Cancer","ValueMeaning":{"publicId":"3419373","version":"1","preferredName":"Stage 0 Breast Cancer","longName":"3419373","preferredDefinition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stage 0 Breast Cancer AJCC v6 and v7","conceptCode":"C3641","definition":"Stage 0 includes: Tis, N0, M0.  Tis: Carcinoma in situ.  N0: No regional lymph node metastasis.  M0: No distant metastasis. (AJCC 6th and 7th eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-19AB-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Updated VMD with latest version of NCIt concept defintion. mc 3/20/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB9ECD53-19C4-8642-E040-BB89AD43080C","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3419356","version":"1","preferredName":"Breast Cancer TNM Finding v7 American Joint Committee on Cancer Stage Grouping Stage","preferredDefinition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88257:C39315:C38027:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer TNM Finding v7","conceptCode":"C88257","definition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Stage Grouping","conceptCode":"C38027","definition":"An assessment based on the combined evaluation of the patient's T stage, M stage, and N stage, as well as prognostic parameters for specific cancers.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-1849-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"ONEDATA","dateModified":"2012-03-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB9ECD53-185A-8642-E040-BB89AD43080C","latestVersionIndicator":"Yes","beginDate":"2012-03-19","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-03-19","modifiedBy":"MAESKEB","dateModified":"2022-03-15","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3021954","version":"1","longName":"Caris Life Sciences","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3060675","version":"1","longName":"Biospecimen Repository","context":"NCIP"},{"publicId":"10000006","version":"1","longName":"Breast","context":"NCIP"}]},{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461588","version":"1","longName":"General Elements","context":"NCIP"}]},{"publicId":"3886753","version":"1","longName":"General Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902138","version":"1","longName":"General","context":"BOLD"}]}],"AlternateNames":[{"name":"BOLD","type":"USED_BY","context":"BOLD"},{"name":"CTEP","type":"USED_BY","context":"CTEP"}],"ReferenceDocuments":[{"name":"Pathologic Group Stage","type":"Preferred Question Text","description":"Pathologic Group Stage","url":null,"context":"NCIP"},{"name":"Stage Grouping","type":"Alternate Question Text","description":"Stage Grouping","url":null,"context":"NCIP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Pathological AJCC stage","url":null,"context":"CTEP"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D488DDBA-7EF6-519A-E040-BB89AD43303A","latestVersionIndicator":"Yes","beginDate":"2013-01-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-30","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Created for specific use on Caris form per request by B.Maeske. mc 1/30/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}